Lead Product(s) : Gadoteridol
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Gadoteridol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Brain Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 07, 2012
Lead Product(s) : Gadoteridol
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
